AJP - GI Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 281: G311-G315, 2001;
0193-1857/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blackshaw, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blackshaw, L. A.
Vol. 281, Issue 2, G311-G315, August 2001

THEME
Receptors and Transmission in the Brain-Gut Axis: Potential for Novel Therapies
IV. GABAB receptors in the brain-gastroesophageal axis

L. Ashley Blackshaw

Nerve-Gut Research Laboratory, Department of Gastroenterology, Hepatology and General Medicine, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia 5000, Australia

GABAB receptors are inhibitory G protein-coupled receptors that are commonly associated with presynaptic inhibition of transmitter release in the central nervous system. In the brain-gastroesophageal axis, a role has recently been demonstrated for GABAB receptors on extrinsic afferent endings within the stomach and esophagus, where they reduce mechanosensitivity. This action is compounded by inhibition of communication centrally from these afferents in the brain stem and within central circuits. There is a final peripheral action on the motor pathway where GABAB receptors reduce output of acetylcholine from vagal preganglionic motoneurons. These potent, multiple actions of GABAB receptors may have therapeutic benefit by reducing the triggering of transient lower esophageal relaxations, which are the major cause of gastroesophageal reflux. An important clinical application is therefore emerging for this recent discovery.

vagal afferents; mechanoreceptors; transient lower esophageal relaxations; gastroesophageal reflux


This article has been cited by other articles:


Home page
J. Physiol.Home page
A. J. Page, J. A. Slattery, S. M. Brierley, A. S. Jacoby, and L. A. Blackshaw
Involvement of galanin receptors 1 and 2 in the modulation of mouse vagal afferent mechanosensitivity
J. Physiol., September 1, 2007; 583(2): 675 - 684.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. J. Page, J. A. Slattery, C. Milte, R. Laker, T. O'Donnell, C. Dorian, S. M. Brierley, and L. A. Blackshaw
Ghrelin selectively reduces mechanosensitivity of upper gastrointestinal vagal afferents
Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1376 - G1384.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. N. Browning, Z. Zheng, T. W. Gettys, and R. A. Travagli
Vagal afferent control of opioidergic effects in rat brainstem circuits
J. Physiol., September 15, 2006; 575(3): 761 - 776.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
W.-Y. Lu, Y.-Y. Xiang, W. Ju, M. Liu, and B. Orser
26167 - A-TYPE GAMMA-AMINOBUTYRIC ACID RECEPTOR (GABAAR) AND GLUTAMIC ACID DECARBOXYLASE (GAD) IN TYPE II PNEUMOCYTES
Can J Anesth, June 1, 2006; 53(suppl_1): 26167 - 26167.
[Full Text] [PDF]


Home page
GutHome page
A J Page, S M Brierley, C M Martin, M P Price, E Symonds, R Butler, J A Wemmie, and L A Blackshaw
Different contributions of ASIC channels 1a, 2, and 3 in gastrointestinal mechanosensory function
Gut, October 1, 2005; 54(10): 1408 - 1415.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. J Page, J. A Slattery, T. A O'Donnell, N. J Cooper, R. L Young, and L. A. Blackshaw
Modulation of gastro-oesophageal vagal afferents by galanin in mouse and ferret
J. Physiol., March 15, 2005; 563(3): 809 - 819.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Hayashi, M. Otsuka, R. Morimoto, A. Muroyama, S. Uehara, A. Yamamoto, and Y. Moriyama
Vesicular Inhibitory Amino Acid Transporter Is Present in Glucagon-Containing Secretory Granules in {alpha}TC6 Cells, Mouse Clonal {alpha}-Cells, and {alpha}-Cells of Islets of Langerhans
Diabetes, August 1, 2003; 52(8): 2066 - 2074.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. E. Raybould
The Future of GI and Liver Research: Editorial Perspectives: IV. Visceral afferents: an update
Am J Physiol Gastrointest Liver Physiol, June 1, 2003; 284(6): G880 - G882.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. N. Sengupta, B. K. Medda, and R. Shaker
Effect of GABAB receptor agonist on distension-sensitive pelvic nerve afferent fibers innervating rat colon
Am J Physiol Gastrointest Liver Physiol, December 1, 2002; 283(6): G1343 - G1351.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online